Trials / Available
AvailableNCT07421557
Expanded Access of Occlutech's Atrial Flow Regulator
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Occlutech International AB · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Occlutech AFR use allowed per FDA's Expanded Access program.
Detailed description
Occlutech AFR use allowed per FDA's Expanded Access program. Each individual request is sent for FDA approval and the site's IRB approval per regulations.
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Catheter implantation of Occlutech AFR device |
Timeline
- First posted
- 2026-02-19
- Last updated
- 2026-02-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07421557. Inclusion in this directory is not an endorsement.